FDA Investigator Charles M Spyr

Charles M Spyr has inspections in 4 countries as of 01 Nov 2023. Charles M Spyr has collaborated with a combinined 3637 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
303
Last Inspection Date:
01 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
100007090
Country:
United States of America, Italy, Germany, Finland
Co-Investigator(s):
A Williams, Adam J Taylor, Alan C Gion, Alanna Lmussawwir Bias, Alberto Gutierrez, PhD, Allison E Sincek, Allison M Scheck, Amber M Capello Jones, Amina Bashir, Amy S Graf, Anastacia Mpiliafas Brown, Andrea D Swingle, Andrew H Paeng, Andrew Saunders, Anthony R Petriella, Art O Czabaniuk, Ava M Bowman, Azza Talaat, Barbara A Rusin, Bei Y He, Benjamin J Dastoli, Benjamin J Smith, Bernard P Heidt, Beverley A Phillips, Bleta Vuniqi, Brandi N Mcgrady, Brentley S Collins, Brian J Mundo, Brian M Campbell, Brian M Marosan, Brian R Yaun, Brittany M Lowe, Bruce, Bryan J Love, Burnell M Henry, Calvin K Cook, Catherine V Quinlan, CDR Kimberly Y Martin, CDR Sean T Creighton, Charles E Frelix, Charles M Sypr, Cheng H Yen, Christina L Bigham, Christopher C Wilcox, Constantin Y Philopoulos, Corrine M Carter, Crystal M Young Lewis, Cynthia A Harris, MD, RN, Cynthia L Aycock, Cynthia Li, Cynthia T Cain, Daniel J Gorski, Daniel J Lahar, David A Paterson, David J Gasparovich, David J Gsparovich, David L Duncan, Dawn C Olenjack, Deanna L Lampley, Debara R Reese, Delkis J Caycedo, Dennis E Swartz, Dennis R Hock, Don A Leeseberg, Donald W Myrick, Downer, Edward D Mcdonald, Edwardstine J Reese, Emest F Bizjak, Emily J Orban, Emmanuel A Dimaano, Jr, Enrico Joset Mangahis, Eric E Joneson, Eric S Pittman, Erma Zaimova, Everard A Irish, Gary Durbiel Goldner, George G Calafactor, Gerald D Bromley, Jr, Hans T Meyers, Harperd, Helen B Ricalde, Ian A Pilcher, Ifueko Osemwota, Ismael Olvera, IV, Jaclyn N Munsch, Jacqueline M Bowling, James A Lane, James E Szelc, James M Odonnell, Jeanne F Broderick, Jeffrey A Sincek, Jeffrey A Sommers, Jeffrey D Meng, Jeffrey J Thibodeau, Jennifer L Johnson, Jennifer L Schmidt, Jennifer R Johnson, Joan A Loreng, John N Woodall, Joseph R Strelnik, Joshua M Adams, Joshua S Hoeh, Judith A Jankowski, Juliane C Lessard, K Gonzlez, Kennita Riddick, Kimberly Lewandowski Walker, Kinh Q Mac, Kristina Mezin, Kristina Nastovski, L'oreal F Walker, Larry K Austin, Laureen M Geniusz, Lauren E Burke, Lauren E Sexton, Laurie B Frazier, LCDR Anastasia Mpiliafas Brown, LCDR Matthew J Morrison, Leigh Anne Myers, Leo J Lagrotte, Leonard Pesetsky, Lesley Maep Lutao, Lewis K Antwi, Lisa P Oakes, Mancia R Walker, Margaret A Foster, Maribeth G Grattan, Maribeth G Niesen, Maricelys Mercado, Marissa S Steinhagen, Martha Sullivan Myrick, Martin R Vowell, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melina Lrodriguez Upton, Michael C Ireland, Michael E Cimaglio, Michele L Forster, PhD, Michele L Glendenning, Minerva Rogers, Monica J Wilkins, Mpris Inspector, Msdap Gonzlezk, Muna Algharibeh, Myra K Casey, Nancy A Bellamy, Nancy L Neiger, Natalie A Mickelsen, DVM, Neal D Singletary, PhD, Nerizza B Guerin, Norman Wong, Pablo Alcantara, Patricia A Cochran, Patricia A Mcilroy, Patricia H Dlugosz, Patrick B Cummings, Patsy J Domingo, Paul A Licata, Paula A Trost, Paula P Demichael, Peng Zhou, Peter R Lenahan, Rachel T Evans, Rafeeq A Habeeb, Ralph A Erickson, Rebecca E Dombrowski, Rebecca K Olin, Robert E Davis, Robert G Taylor, Robert M Barbosa, Rosanna M Goodrich, Rose M Ashley, Rterry Bolen, Ryan J Benedict, Sara M Onyango, Sarah B Tanksley, Sarah L Clark, Sarah M Meng, Sarah M Napier, Sargum C Sood, Scott T Ballard, Scotty L Hargrave, Sean R Bryd, Sherri J Jackson, Simone E Pitts, State Agency, Stephanie Mangigian, MS/OSH, RN, Susan M Jackson, Susan M Miller, Susan M North, Suyang Qin, Talmane J Fisher, Tamayo C Barnes, Tania E Vizcaino, Terri L Jones, Thomas A Peter, Toni S Sturgis, Travis S Bradley, Vera M Anderson, Vickie L Adkins, Wendy M Stark, William D Tingley, William R Brubaker

Charles M Spyr's Documents

Publish Date Document Type Title
April, 2004 EIR Cook Incorporated - EIR, 2004-04-29
May, 2009 FDA 483 Response Stryker Medical Division of Stryker Corporation - Form 483R, 2009-06-12
June, 2001 EIR Cook Incorporated - EIR, 2001-06-06
May, 2009 FDA 483 Response Stryker Instruments Div. of Stryker Corporation - Form 483R, 2009-06-16
April, 2005 FDA 483 CrestLab, Inc. - Form 483, 2005-04-28
May, 2009 FDA 483 Stryker Instruments Div. of Stryker Corporation - Form 483, 2009-05-14
March, 2003 FDA 483 Roche Diagnostics Operations, Inc. - Form 483, 2003-03-27
June, 2004 FDA 483 Roche Diagnostics Operations, Inc. - Form 483, 2004-06-28
November, 2000 EIR Universal Reagents, Inc. - EIR, 2000-11-03
March, 2008 FDA 483 Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc. - Form 483, 2008-04-03
September, 2001 FDA 483 Roche Diagnostics Operations, Inc. - Form 483, 2001-09-27
March, 2003 EIR Roche Diagnostics Operations, Inc. - EIR, 2003-03-27
January, 2009 FDA 483 Hill-Rom, Inc. - Form 483, 2009-01-23
August, 2009 FDA 483 Symbios Medical Products, LLC - Form 483, 2009-09-01
November, 2001 FDA 483 Response Cook Incorporated - Form 483R, 2001-12-26
December, 2002 EIR Cook Incorporated - EIR, 2002-12-12
March, 2010 FDA 483 Terumo Cardiovascular Systems Corporation - Form 483, 2010-03-29
March, 2003 FDA 483 Response Roche Diagnostics Operations, Inc. - Form 483R, 2003-04-18
June, 2000 FDA 483 Universal Reagents, Inc. - Form 483, 2000-06-16
September, 2007 FDA 483 Zimmer, Inc. - Form 483, 2007-09-17
November, 2001 EIR Cook Incorporated - EIR, 2001-11-08
March, 2004 EIR Roche Diagnostics Operations, Inc. - EIR, 2004-03-15
May, 2009 FDA 483 Stryker Medical Division of Stryker Corporation - Form 483, 2009-05-15
November, 2000 FDA 483 Universal Reagents, Inc. - Form 483, 2000-11-03
December, 2005 EIR Cook Incorporated - EIR, 2005-12-06
December, 2002 FDA 483 Response Cook Incorporated - Form 483R, 2002-12-13
July, 2003 FDA 483 Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc. - Form 483, 2003-07-11
December, 2002 FDA 483 Cook Incorporated - Form 483, 2002-12-12
March, 2004 FDA 483 Response Roche Diagnostics Operations, Inc. - Form 483R, 2004-04-05
June, 2001 FDA 483 Cook Incorporated - Form 483, 2001-06-06
November, 2001 FDA 483 Cook Incorporated - Form 483, 2001-11-08
June, 2000 EIR Universal Reagents, Inc. - EIR, 2000-06-16
March, 2004 FDA 483 Roche Diagnostics Operations, Inc. - Form 483, 2004-03-15

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more